Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the Cognitive Behavioral Therapy - Based Resilience Development Program Applied to Schizophrenia Patients on Resilience and Functionality

NCT05739344 is registered in ClinicalTrials.gov with Sisli Hamidiye Etfal Training and Research Hospital as lead sponsor.

NCT NCT05739344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the Cognitive Behavioral Therapy - Based Resilience Development Program Applied to Schizophrenia Patients on Resilience and Functionality
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2022
Completion date
March 1, 2023
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia